tiprankstipranks
Advertisement
Advertisement

MNKD Stock Latest News

MannKind reports Q1 EPS (2c), consensus 1c
The FlyMannKind reports Q1 EPS (2c), consensus 1c
3h ago
MNKD
MannKind Buy Rating Reiterated as United Therapeutics Expands DPI Partnership; $8 Price Target Unchanged
PremiumRatings
MannKind Buy Rating Reiterated as United Therapeutics Expands DPI Partnership; $8 Price Target Unchanged
10h ago
MNKD
MNKD Earnings this Week: How Will it Perform?
PremiumPre-Earnings
MNKD Earnings this Week: How Will it Perform?
3d ago
MNKD
MannKind’s Inhaled Nintedanib Trial: Early IPF Study Moves Forward
PremiumCompany Announcements
MannKind’s Inhaled Nintedanib Trial: Early IPF Study Moves Forward
20d ago
MNKD
MannKind price target lowered to $8 from $10 at Mizuho
PremiumThe Fly
MannKind price target lowered to $8 from $10 at Mizuho
24d ago
MNKD
MannKind price target lowered to $6 from $7 at Truist
PremiumThe FlyMannKind price target lowered to $6 from $7 at Truist
29d ago
MNKD
Theravance Biopharma price target raised to $17 from $14 at B. Riley
Premium
The Fly
Theravance Biopharma price target raised to $17 from $14 at B. Riley
30d ago
MNKD
TBPH
MannKind price target lowered to $8 from $10 at Wedbush
Premium
The Fly
MannKind price target lowered to $8 from $10 at Wedbush
2M ago
MNKD
UTHR
Biotech Bloodbath Drags Health Care Down as MannKind and Soleno Stocks Sink
PremiumMarket News
Biotech Bloodbath Drags Health Care Down as MannKind and Soleno Stocks Sink
2M ago
IBB
XBI
MannKind price target lowered to $7 from $8 at Wells Fargo
PremiumThe Fly
MannKind price target lowered to $7 from $8 at Wells Fargo
2M ago
MNKD
MannKind price target lowered to $8 from $11 at H.C. Wainwright
PremiumThe Fly
MannKind price target lowered to $8 from $11 at H.C. Wainwright
2M ago
MNKD
MannKind downgraded to Sector Perform from Outperform at RBC Capital
PremiumThe Fly
MannKind downgraded to Sector Perform from Outperform at RBC Capital
2M ago
MNKD
UTHR
MannKind reports Q4 EPS (5c) vs 3c last year
PremiumThe FlyMannKind reports Q4 EPS (5c) vs 3c last year
2M ago
MNKD
RBC says United Therapeutics TreSMI presents ‘material risk’ to MannKind
Premium
The Fly
RBC says United Therapeutics TreSMI presents ‘material risk’ to MannKind
2M ago
MNKD
UTHR
Leerink sees MannKind selloff as ‘overreaction’ to headline news
Premium
The Fly
Leerink sees MannKind selloff as ‘overreaction’ to headline news
2M ago
MNKD
UTHR
H.C. Wainwright sees MannKind selloff ‘potentially resetting’ value proposition
PremiumThe Fly
H.C. Wainwright sees MannKind selloff ‘potentially resetting’ value proposition
2M ago
MNKD
UTHR
United Therapeutics announces ‘category killer product’ Tresmi
PremiumThe Fly
United Therapeutics announces ‘category killer product’ Tresmi
2M ago
MNKD
UTHR
MannKind sinks after United Therapeutics announces soft-mist inhaler
PremiumThe Fly
MannKind sinks after United Therapeutics announces soft-mist inhaler
2M ago
MNKD
UTHR
Is MNKD a Buy, Before Earnings?
PremiumPre-Earnings
Is MNKD a Buy, Before Earnings?
2M ago
MNKD
MannKind: Pediatric Expansion, Improved Dosing, and Pipeline Diversification Drive Buy Rating on Afrezza Growth Potential
PremiumRatingsMannKind: Pediatric Expansion, Improved Dosing, and Pipeline Diversification Drive Buy Rating on Afrezza Growth Potential
3M ago
MNKD
MannKind says first patient enrolled in INHALE-1ST study of Afrezza
Premium
The Fly
MannKind says first patient enrolled in INHALE-1ST study of Afrezza
3M ago
MNKD
Morning Movers: USA Rare Earth surges after government funding pact
Premium
The Fly
Morning Movers: USA Rare Earth surges after government funding pact
3M ago
AAUC
CRWV

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >